Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID combination vaccine for approval in 2024Announces positive ...

Expects to submit next-generation COVID vaccine for approval in 2024 Expects to submit flu/COVID combination vaccine for approval in 2024 Announces positive Phase 3 results for its RSV vaccine for ...

Image Source: Zacks Investment Research Spikevax, targeting the variant JN.1., is currently approved in the United States, the United Kingdom, Japan and Taiwan. Last month, the FDA approved ...

It can perform a host of tasks beyond just putting words down, including a very handy function for creating mailing labels. In this guide, we're going to show you how to print labels from Word ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an adapted Moderna COVID-19 vaccine (Spikevax) that targets the JN.1 COVID-19 subvariant. This vaccine is licensed for ...

For the first time in the UK, the updated vaccine, Spikevax® JN.1, will also be available to purchase privately for those who are not eligible for the NHS Autumn vaccination program. The updated ...

In the month, the US regulatory agency approved and granted EUAs to two updated mRNA vaccines, namely Moderna’s Spikevax and Pfizer / BioNTech’s Comirnaty. Both mRNA vaccines were approved for ...

has approved an updated formulation of the COVID-19 mRNA vaccine Spikevax, targeting the SARS-CoV-2 variant JN.1., for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals ...

The emergency use authorisation from the FDA allows for Novavax’s updated Covid-19 vaccine to be used in individuals 12 years and older. Credit: Aha-Soft / Shutterstock. Novavax has joined its peers ...